COMPANY PROFILE · UPDATED 18 NOV 2025
Areteia Therapeutics
Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma.
This profile is unclaimed — do you work here? Claim it
Claim it →- Founded
- 2022
- Headcount
- 27
- Open roles
- 0
- Last raised
- Series A · Sign in to view
LEADERSHIP
Founders & key people
OPEN ROLES
Hiring at Areteia Therapeutics
No open roles listed right now. Check back soon or search all jobs →
FUNDING
Capital raised
TAGS
Categorized in
Company Collections
These are collections Areteia Therapeutics is a part of. Click on the collection name to view similar companies.
Areteia Therapeutics' Investors
Areteia Therapeutics' Industries
LOCATIONS
Where they work
Areteia Therapeutics Headquarters Location
101 Glen Lennox Dr suite 300, Chapel Hill, NC, 27517
Loading map…